February 3, 2010 2:40 PM
- Text
UPDATED: Pfizer's Penis-Straightening Drug Gets an FDA Approval
(MoneyWatch)
BNET readers will remember that Pfizer entered a $75 million pact with Auxilium for the development of Xiaflex in December 2008. And while the pair are developing the compound for use to combat Dupuytren's contracture (where patients' hands contract into claws), everyone knows that the other potential use Xiaflex has is for Peyronie's disease, or curvature of the penis from a buildup of fibrous tissue in the shaft. You can see Auxilium has a trial ongoing here, and the drug in question, "AA4500," is the same as that used in the Xiaflex trials here.
With the drug now heading to market, the question now is how much of the drug's sales will be for the off-label Peyronie's indication? I'm betting not much: Even though the drug works in straightening rats' tails it must still be administered by injection at the site of the organ, and that can cause bruising.
An Auxilium representative denied that the drug would be used off-label for Peyronies, and added that there were "multiple errors" in this item:
- UPDATE: Auxilium responds to this article, and denies there is any current intent to use the drug for penis curvature. See below.
BNET readers will remember that Pfizer entered a $75 million pact with Auxilium for the development of Xiaflex in December 2008. And while the pair are developing the compound for use to combat Dupuytren's contracture (where patients' hands contract into claws), everyone knows that the other potential use Xiaflex has is for Peyronie's disease, or curvature of the penis from a buildup of fibrous tissue in the shaft. You can see Auxilium has a trial ongoing here, and the drug in question, "AA4500," is the same as that used in the Xiaflex trials here.With the drug now heading to market, the question now is how much of the drug's sales will be for the off-label Peyronie's indication? I'm betting not much: Even though the drug works in straightening rats' tails it must still be administered by injection at the site of the organ, and that can cause bruising.
An Auxilium representative denied that the drug would be used off-label for Peyronies, and added that there were "multiple errors" in this item:
First, XIAFLEX is not Pfizer's drug ?€" it's Auxilium's. Pfizer is our marketing partner only for Europe. Second, and most importantly, XIAFLEX just received FDA approval as the first nonsurgical treatment for Dupuytren's contracture and that's the drug's only approved indication. Although being studied in Peyronie's disease, we only announced Phase IIb data in December and are nowhere near a point to grant that indication. To suggest the possibility of off-label use for Peyronie's is reckless and potentially damaging.Image by Flickr user elsie.esq, CC.
Latest Now in MoneyWatch
- States, Feds to announce new mortgage settlement
- Management changes at Ford
- Unemployment aid applications near a 4-year low
- PepsiCo's net rises; plans to cut 8,700 jobs
- Smartr: A brilliant contacts app for smartphones
- What happens if your insurance company fails?
- Student loan debt: the next financial disaster?
- Investing: Four words that can rob you blind
- How to get the fastest tax refund
- 10 employee types that drive managers crazy
- How leaders know it's time to quit
- Greece fails to agree terms with EU creditors
- 5 banks in $26B settlement with feds over abuses
- Gas prices continue to creep up
- Joe Coffee | Secrets of Successful Startups
- Small business mistake: coasting on past success
- Groupon's revenue, losses grow quarter to quarter
Latest CBS News Headlines
on Facebook
on CBS News
- States, Feds to announce new mortgage settlement
- Kodak to stop making cameras, digital frames
- Kodak to stop making cameras, digital frames
- Zebras' stripes tell nasty flies to buzz off
on Facebook
- Calif. surfer runs fastest-growing camera company
- Mo. teen gets life in prison for murder of 9-year-old girl
- "Person to Person": Bon Jovi behind the scenes
- Zsa Zsa at 95: Husband releases birthday photos
on CBS News






